N

Noile-Immune Biotech Inc
TSE:4893

Watchlist Manager
Noile-Immune Biotech Inc
TSE:4893
Watchlist
Price: 136 JPY 1.49% Market Closed
Market Cap: 5.9B JPY

Intrinsic Value

The intrinsic value of one Noile-Immune Biotech Inc stock under the Base Case scenario is 83.97 JPY. Compared to the current market price of 136 JPY, Noile-Immune Biotech Inc is Overvalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
83.97 JPY
Overvaluation 38%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
Noile-Immune Biotech Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about Noile-Immune Biotech Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Noile-Immune Biotech Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Noile-Immune Biotech Inc.

Explain Valuation
Compare Noile-Immune Biotech Inc to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Noile-Immune Biotech Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Noile-Immune Biotech Inc

Current Assets 4.4B
Cash & Short-Term Investments 4.3B
Receivables 16.4m
Other Current Assets 27.6m
Non-Current Assets 24.4m
Other Non-Current Assets 24.4m
Current Liabilities 62.8m
Accrued Liabilities 28.1m
Other Current Liabilities 34.8m
Non-Current Liabilities 5.2m
Other Non-Current Liabilities 5.2m
Efficiency

Free Cash Flow Analysis
Noile-Immune Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Noile-Immune Biotech Inc

Revenue
9.3m JPY
Operating Expenses
-809.2m JPY
Operating Income
-799.9m JPY
Other Expenses
107.2m JPY
Net Income
-692.7m JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Noile-Immune Biotech Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Strong 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
20/100
Profitability
Score

Noile-Immune Biotech Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Noile-Immune Biotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Noile-Immune Biotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Noile-Immune Biotech Inc

There are no price targets for Noile-Immune Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Noile-Immune Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Noile-Immune Biotech Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Noile-Immune Biotech Inc stock?

The intrinsic value of one Noile-Immune Biotech Inc stock under the Base Case scenario is 83.97 JPY.

Is Noile-Immune Biotech Inc stock undervalued or overvalued?

Compared to the current market price of 136 JPY, Noile-Immune Biotech Inc is Overvalued by 38%.

Back to Top